HK Stock MarketDetailed Quotes

02157 LEPU BIO-B

Watchlist
  • 2.560
  • +0.130+5.35%
Not Open Aug 30 16:08 CST
4.38BMarket Cap-54468P/E (TTM)

LEPU BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
-13.20%133.28M
1,347.16%225.35M
--153.55M
--15.57M
----
----
----
----
Operating income
-13.20%133.28M
1,347.16%225.35M
153.55M
15.57M
Cost of sales
-265.63%-21.04M
-1,310.32%-28.28M
---5.76M
---2.01M
----
----
----
----
Operating expenses
-265.63%-21.04M
-1,310.32%-28.28M
-5.76M
-2.01M
Gross profit
-24.06%112.24M
1,352.61%197.08M
147.8M
13.57M
Selling expenses
-216.05%-43.79M
-2,375.47%-43.3M
---13.86M
---1.75M
----
----
----
----
Administrative expenses
21.06%-30.84M
37.58%-86.66M
53.88%-39.07M
11.14%-138.83M
---84.73M
-66.64%-156.24M
51.05%-93.76M
---191.55M
Research and development expenses
6.58%-216.61M
12.63%-458.07M
-0.51%-231.87M
33.74%-524.29M
---230.71M
-123.24%-791.21M
-54.64%-354.43M
---229.2M
Revaluation surplus
-100.70%-124K
378.55%174.98M
129.18%17.74M
17.66%-62.82M
---60.78M
2.19%-76.29M
-103.57%-77.99M
---38.31M
-Changes in the fair value of financial assets
----
----
----
----
---60.78M
----
-103.57%-77.99M
---38.31M
-Changes in the fair value of other assets
-100.70%-124K
378.55%174.98M
--17.74M
17.66%-62.82M
----
---76.29M
----
----
Special items of operating profit
-486.61%-4.91M
2,192.30%220.77M
-76.98%1.27M
-31.68%9.63M
--5.52M
142.03%14.1M
32.21%5.82M
--4.41M
Operating profit
-55.97%-184.04M
100.68%4.8M
68.17%-118M
30.22%-704.48M
-370.7M
-94.03%-1.01B
-14.45%-520.35M
-454.66M
Financing income
-53.48%2.57M
-82.01%8.26M
-84.96%5.53M
1,008.35%45.92M
--36.75M
-21.92%4.14M
1,236.52%5.31M
--397K
Financing cost
-6.65%-8.47M
-85.23%-16.02M
-184.48%-7.94M
-52.21%-8.65M
---2.79M
93.42%-5.68M
-64.23%-86.32M
---52.56M
Special items of earning before tax
67.27%-7.04M
15.17%-27.34M
-84.67%-21.5M
-82.15%-32.23M
---11.64M
-46.43%-17.7M
-39.30%-12.08M
---8.68M
Earning before tax
-38.80%-196.97M
95.67%-30.3M
59.27%-141.9M
32.02%-699.44M
-348.37M
-67.72%-1.03B
-19.00%-613.45M
-515.49M
After-tax profit from continuing operations
-38.80%-196.97M
95.67%-30.3M
59.27%-141.9M
32.02%-699.44M
-348.37M
-67.72%-1.03B
-19.00%-613.45M
-515.49M
Earning after tax
-38.80%-196.97M
95.67%-30.3M
59.27%-141.9M
32.02%-699.44M
-348.37M
-67.72%-1.03B
-19.00%-613.45M
-515.49M
Minority profit
---4.54M
21.02%-8.21M
----
41.87%-10.39M
---4.09M
43.44%-17.87M
53.84%-31.6M
---68.46M
Profit attributable to shareholders
-35.61%-192.43M
96.79%-22.1M
58.78%-141.9M
31.84%-689.05M
-344.29M
-73.76%-1.01B
-30.16%-581.85M
-447.04M
Basic earnings per share
-33.33%-0.12
97.62%-0.01
57.14%-0.09
36.36%-0.42
-0.21
-29.41%-0.66
26.09%-0.51
-0.69
Diluted earnings per share
-33.33%-0.12
97.62%-0.01
57.14%-0.09
36.36%-0.42
-0.21
-29.41%-0.66
26.09%-0.51
-0.69
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
PricewaterhouseCoopers
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover -13.20%133.28M1,347.16%225.35M--153.55M--15.57M----------------
Operating income -13.20%133.28M1,347.16%225.35M153.55M15.57M
Cost of sales -265.63%-21.04M-1,310.32%-28.28M---5.76M---2.01M----------------
Operating expenses -265.63%-21.04M-1,310.32%-28.28M-5.76M-2.01M
Gross profit -24.06%112.24M1,352.61%197.08M147.8M13.57M
Selling expenses -216.05%-43.79M-2,375.47%-43.3M---13.86M---1.75M----------------
Administrative expenses 21.06%-30.84M37.58%-86.66M53.88%-39.07M11.14%-138.83M---84.73M-66.64%-156.24M51.05%-93.76M---191.55M
Research and development expenses 6.58%-216.61M12.63%-458.07M-0.51%-231.87M33.74%-524.29M---230.71M-123.24%-791.21M-54.64%-354.43M---229.2M
Revaluation surplus -100.70%-124K378.55%174.98M129.18%17.74M17.66%-62.82M---60.78M2.19%-76.29M-103.57%-77.99M---38.31M
-Changes in the fair value of financial assets -------------------60.78M-----103.57%-77.99M---38.31M
-Changes in the fair value of other assets -100.70%-124K378.55%174.98M--17.74M17.66%-62.82M-------76.29M--------
Special items of operating profit -486.61%-4.91M2,192.30%220.77M-76.98%1.27M-31.68%9.63M--5.52M142.03%14.1M32.21%5.82M--4.41M
Operating profit -55.97%-184.04M100.68%4.8M68.17%-118M30.22%-704.48M-370.7M-94.03%-1.01B-14.45%-520.35M-454.66M
Financing income -53.48%2.57M-82.01%8.26M-84.96%5.53M1,008.35%45.92M--36.75M-21.92%4.14M1,236.52%5.31M--397K
Financing cost -6.65%-8.47M-85.23%-16.02M-184.48%-7.94M-52.21%-8.65M---2.79M93.42%-5.68M-64.23%-86.32M---52.56M
Special items of earning before tax 67.27%-7.04M15.17%-27.34M-84.67%-21.5M-82.15%-32.23M---11.64M-46.43%-17.7M-39.30%-12.08M---8.68M
Earning before tax -38.80%-196.97M95.67%-30.3M59.27%-141.9M32.02%-699.44M-348.37M-67.72%-1.03B-19.00%-613.45M-515.49M
After-tax profit from continuing operations -38.80%-196.97M95.67%-30.3M59.27%-141.9M32.02%-699.44M-348.37M-67.72%-1.03B-19.00%-613.45M-515.49M
Earning after tax -38.80%-196.97M95.67%-30.3M59.27%-141.9M32.02%-699.44M-348.37M-67.72%-1.03B-19.00%-613.45M-515.49M
Minority profit ---4.54M21.02%-8.21M----41.87%-10.39M---4.09M43.44%-17.87M53.84%-31.6M---68.46M
Profit attributable to shareholders -35.61%-192.43M96.79%-22.1M58.78%-141.9M31.84%-689.05M-344.29M-73.76%-1.01B-30.16%-581.85M-447.04M
Basic earnings per share -33.33%-0.1297.62%-0.0157.14%-0.0936.36%-0.42-0.21-29.41%-0.6626.09%-0.51-0.69
Diluted earnings per share -33.33%-0.1297.62%-0.0157.14%-0.0936.36%-0.42-0.21-29.41%-0.6626.09%-0.51-0.69
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopersPricewaterhouseCoopersPricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg